Contact Us   |   Sign In   |   Join
Collaborate2Cure: Autism Spectrum Disorders
Tell a Friend About This EventTell a Friend

BioNexus KC announced their 2020 Collaborate2Cure series on Autism Spectrum Disorders (ASD). Events will occur monthly beginning June 10, 2020 via the ZOOM meeting platform. The Kansas City region has a robust autism network comprised of basic researchers, clinicians, patient advocacy groups, and start-up companies. The Collaborate2Cure program provides a platform for collaboration, allowing scientists in the Kansas City region to share their research and ultimately compete for funding dollars.

 Export to Your Calendar 6/10/2020
When: Wednesday, June 10, 2020
4:00 pm
Where: Webinar
United States
Contact: Jennifer Lindholm

« Go to Upcoming Event List  

The short-term goal is to combine these disciplines to learn about a variety of research and clinical issues related to ASD. With each having a unique window into the topic, chances are very good that new collaborations may spark innovative treatments, diagnostics, advocacy strategies, and broadened awareness. The long-term goal of the series will be to formalize a consortium of researchers, clinicians, and patient advocates devoted to ASD progress and research.

Collectively, the consortium will make the region more competitive for research funding, support more targeted clinical interventions, and raise regional awareness of the impact of ASD on individuals and their families. At the conclusion of the series, a request for proposals will be released to support collaborative, innovative research projects generated from the discussions at a funding level of $50,000 for up to one year.

Scientific collaboration can cultivate more creativity, increase funding and result in higher impact publications. For all these reasons, BioNexus KC created Collaborate2Cure with the goal of stimulating regional scientific collaboration and developing innovative ways to solve scientific challenges. Collaborate2Cure was launched in late 2016 and has focused on cancer immunotherapy, mitochondrial dysfunction and value-based healthcare.

Registar Here 

Association Management Software Powered by YourMembership  ::  Legal